{{Rsnum
|rsid=4149639
|Gene=TNFRSF1A
|Chromosome=12
|position=6332835
|Orientation=minus
|GMAF=0.07897
|Gene_s=TNFRSF1A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 79.5 | 18.2 | 2.3
| JPT | 86.4 | 13.6 | 0.0
| YRI | 61.3 | 32.3 | 6.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 79.5 | 18.2 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=7E-6
  |OR=2.76
  |ORtxt=[1.781-4.287]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}